Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have today announced a formal agreement to work together.
14 December, 2017
The outstanding contribution made to life sciences by entrepreneur Dr Stephen Little, Chief Executive of AIM-listed molecular diagnostics company Premaitha Health, was recognised last night at the 16th annual Bionow Awards.
06 December, 2017
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company, MeiraGTx
05 December, 2017